{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T12:57:28Z","timestamp":1785589048450,"version":"3.56.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","award":["C01F670185"],"award-info":[{"award-number":["C01F670185"]}],"id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Economic and Social Development Council"},{"name":"Technology and Innovation in Life Sciences National Agency","award":["TN 3\/2569, TC (ERP) 31\/2568"],"award-info":[{"award-number":["TN 3\/2569, TC (ERP) 31\/2568"]}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A680591, N35E680087"],"award-info":[{"award-number":["N42A680591, N35E680087"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"crossref","award":["RA-MF-22\/69, CE68_028_3000_004"],"award-info":[{"award-number":["RA-MF-22\/69, CE68_028_3000_004"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"DOI":"10.1007\/s00702-026-03257-2","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T12:27:21Z","timestamp":1785587241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["What\u2019s in a name? reframing advanced Parkinson\u2019s disease as a multidimensional state"],"prefix":"10.1007","author":[{"given":"Onanong","family":"Phokaewvarangkul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang H.","family":"Jost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-2064","authenticated-orcid":false,"given":"Roongroj","family":"Bhidayasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"issue":"2","key":"3257_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/08919887231195219","volume":"37","author":"WW Aamodt","year":"2024","unstructured":"Aamodt WW, Kluger BM, Mirham M, Job A, Lettenberger SE, Mosley PE, Seshadri S (2024) Caregiver Burden in Parkinson Disease: A Scoping Review of the Literature from 2017\u20132022. J Geriatr Psychiatry Neurol 37(2):96\u2013113. https:\/\/doi.org\/10.1177\/08919887231195219","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"3257_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.gerinurse.2022.10.010","volume":"48","author":"S Ahn","year":"2022","unstructured":"Ahn S, Springer K, Gibson JS (2022) Social withdrawal in Parkinson\u2019s disease: A scoping review. Geriatr Nurs 48:258\u2013268. https:\/\/doi.org\/10.1016\/j.gerinurse.2022.10.010","journal-title":"Geriatr Nurs"},{"issue":"5","key":"3257_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2217\/nmt-2020-0021","volume":"10","author":"J Aldred","year":"2020","unstructured":"Aldred J, Anca-Herschkovitsch M, Antonini A, Bajenaru O, Bergmann L, Bourgeois P, Cubo E, Davis TL, Iansek R, Kovacs N, Kukreja P, Onuk K, Pontieri FE, Robieson W, Siddiqui MS, Simu M, Standaert DG, Chaudhuri KR (2020) Application of the \u20185-2-1\u2019 screening criteria in advanced Parkinson\u2019s disease: interim analysis of DUOGLOBE. Neurodegener Dis Manag 10(5):309\u2013323. https:\/\/doi.org\/10.2217\/nmt-2020-0021","journal-title":"Neurodegener Dis Manag"},{"issue":"1","key":"3257_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41398-026-04013-6","volume":"16","author":"V Almeida","year":"2026","unstructured":"Almeida V, Herz DM, Blech J, H\u00fclser M, Oertel J, Martens D, Gonz\u00e1lez-Escamilla G, Groppa S (2026) Cognitive trajectories in Parkinson\u2019s disease patients, a review on the impact of subthalamic deep brain stimulation (STN-DBS) and emerging adaptive strategies. Translational Psychiatry 16(1):233. https:\/\/doi.org\/10.1038\/s41398-026-04013-6","journal-title":"Translational Psychiatry"},{"issue":"12","key":"3257_CR5","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1080\/03007995.2018.1502165","volume":"34","author":"A Antonini","year":"2018","unstructured":"Antonini A, Stoessl AJ, Kleinman LS, Skalicky AM, Marshall TS, Sail KR, Onuk K, Odin PLA (2018) Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson\u2019s disease: a multi-country Delphi-panel approach. Curr Med Res Opin 34(12):2063\u20132073. https:\/\/doi.org\/10.1080\/03007995.2018.1502165","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"3257_CR6","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/mdc3.13879","volume":"10","author":"CA Artusi","year":"2023","unstructured":"Artusi CA, Geroin C, Nonnekes J, Aquino C, Garg D, Dale ML, Schlosser D, Lai Y, Al-Wardat M, Salari M, Wolke R, Labou VT, Imbalzano G, Camozzi S, Merello M, Bloem BR, Capato T, Djaldetti R, Doherty K, Fasano A, Tibar H, Lopiano L, Margraf NG, Moreau C, Ugawa Y, Bhidayasiri R, Tinazzi M, International P, Movement Disorders Society Task Force on Postural A (2023) Predictors and Pathophysiology of Axial Postural Abnormalities in Parkinsonism: A Scoping Review. Mov Disord Clin Pract 10(11):1585\u20131596. https:\/\/doi.org\/10.1002\/mdc3.13879","journal-title":"Mov Disord Clin Pract"},{"key":"3257_CR7","doi-asserted-by":"publisher","first-page":"106065","DOI":"10.1016\/j.parkreldis.2024.106065","volume":"123","author":"S Aslam","year":"2024","unstructured":"Aslam S, Manfredsson F, Stokes A, Shill H (2024) Advanced Parkinson\u2019s disease: A review. Parkinsonism Relat Disord 123:106065. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106065","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"3257_CR8","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00702-023-02668-9","volume":"130","author":"M Auffret","year":"2023","unstructured":"Auffret M, Weiss D, Stocchi F, V\u00e9rin M, Jost WH (2023) Access to device-aided therapies in advanced Parkinson\u2019s disease: navigating clinician biases, patient preference, and prognostic uncertainty. J Neural Transm (Vienna) 130(11):1411\u20131432. https:\/\/doi.org\/10.1007\/s00702-023-02668-9","journal-title":"J Neural Transm (Vienna)"},{"key":"3257_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-026-03184-2","author":"Z Azizi","year":"2026","unstructured":"Azizi Z, Setti A, Bruno V, Prehn JHM, Idri A, Ward T (2026) Beyond motor: a systematic review of multisensory integration deficits in Parkinson\u2019s disease. J Neural Transm (Vienna). https:\/\/doi.org\/10.1007\/s00702-026-03184-2","journal-title":"J Neural Transm (Vienna)"},{"issue":"7","key":"3257_CR10","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1212\/wnl.0000000000010084","volume":"95","author":"D B\u00e4ckstr\u00f6m","year":"2020","unstructured":"B\u00e4ckstr\u00f6m D, Linder J, Jakobson Mo S, Riklund K, Zetterberg H, Blennow K, Forsgren L, Lenfeldt N (2020) NfL as a biomarker for neurodegeneration and survival in Parkinson disease. Neurology 95(7):e827\u2013e838. https:\/\/doi.org\/10.1212\/wnl.0000000000010084","journal-title":"Neurology"},{"key":"3257_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/bs.irn.2017.01.001","volume":"132","author":"R Bhidayasiri","year":"2017","unstructured":"Bhidayasiri R, Martinez-Martin P (2017) Clinical Assessments in Parkinson\u2019s Disease: Scales and Monitoring. Int Rev Neurobiol 132:129\u2013182. https:\/\/doi.org\/10.1016\/bs.irn.2017.01.001","journal-title":"Int Rev Neurobiol"},{"issue":"10","key":"3257_CR12","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.parkreldis.2015.08.025","volume":"21","author":"R Bhidayasiri","year":"2015","unstructured":"Bhidayasiri R, Jitkritsadakul O, Boonrod N, Sringean J, Calne SM, Hattori N, Hayashi A (2015) What is the evidence to support home environmental adaptation in Parkinson\u2019s disease? A call for multidisciplinary interventions. Parkinsonism Relat Disord 21(10):1127\u20131132. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.08.025","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"3257_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/WNF.0000000000000361","volume":"42","author":"R Bhidayasiri","year":"2019","unstructured":"Bhidayasiri R, Phokaewvarangkul O, Boonpang K, Boonmongkol T, Thongchuem Y, Kantachadvanich N, Garcia Ruiz PJ (2019) Long-term Apomorphine Infusion Users Versus Short-term Users: An International Dual-center Analysis of the Reasons for Discontinuing Therapy. Clin Neuropharmacol 42(5):172\u2013178. https:\/\/doi.org\/10.1097\/WNF.0000000000000361","journal-title":"Clin Neuropharmacol"},{"issue":"12","key":"3257_CR11","doi-asserted-by":"publisher","first-page":"e0243051","DOI":"10.1371\/journal.pone.0243051","volume":"15","author":"R Bhidayasiri","year":"2020","unstructured":"Bhidayasiri R, Boonmongkol T, Thongchuam Y, Phumphid S, Kantachadvanich N, Panyakaew P, Jagota P, Plengsri R, Chokpatcharavate M, Phokaewvarangkul O (2020a) Impact of disease stage and age at Parkinson\u2019s onset on patients\u2019 primary concerns: Insights for targeted management. PLoS ONE 15(12):e0243051. https:\/\/doi.org\/10.1371\/journal.pone.0243051","journal-title":"PLoS ONE"},{"key":"3257_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2020.02.013","volume":"72","author":"R Bhidayasiri","year":"2020","unstructured":"Bhidayasiri R, Panyakaew P, Trenkwalder C, Jeon B, Hattori N, Jagota P, Wu YR, Moro E, Lim SY, Shang H, Rosales R, Lee JY, Thit WM, Tan EK, Lim TT, Tran NT, Binh NT, Phoumindr A, Boonmongkol T, Phokaewvarangkul O, Thongchuam Y, Vorachit S, Plengsri R, Chokpatcharavate M, Fernandez HH (2020b) Delivering patient-centered care in Parkinson\u2019s disease: Challenges and consensus from an international panel. Parkinsonism Relat Disord 72:82\u201387. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.02.013","journal-title":"Parkinsonism Relat Disord"},{"key":"3257_CR17","doi-asserted-by":"publisher","first-page":"979826","DOI":"10.3389\/fnagi.2022.979826","volume":"14","author":"R Bhidayasiri","year":"2022","unstructured":"Bhidayasiri R, Phuenpathom W, Tan AH, Leta V, Phumphid S, Chaudhuri KR, Pal PK (2022) Management of dysphagia and gastroparesis in Parkinson\u2019s disease in real-world clinical practice - Balancing pharmacological and non-pharmacological approaches. Front Aging Neurosci 14:979826. https:\/\/doi.org\/10.3389\/fnagi.2022.979826","journal-title":"Front Aging Neurosci"},{"key":"3257_CR13","doi-asserted-by":"publisher","first-page":"107894","DOI":"10.1016\/j.parkreldis.2025.107894","volume":"139","author":"R Bhidayasiri","year":"2025","unstructured":"Bhidayasiri R, Lean PL, Chaudhuri KR (2025) Defining \u2018OFF\u2019 time in device-aided therapy criteria for Parkinson\u2019s disease: gaps and opportunities. Parkinsonism Relat Disord 139:107894. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107894","journal-title":"Parkinsonism Relat Disord"},{"key":"3257_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/1877718X261466810","author":"R Bhidayasiri","year":"2026","unstructured":"Bhidayasiri R, Schneider RB, Maetzler W, Espay AJ, Lim TT, Phoumindr A, Kumar H, Pilotto A, Bloem BR (2026) Bridging the global Parkinson\u2019s divide: Technology as a structural solution for equitable and brain health-integrated care. J Parkinsons Dis. https:\/\/doi.org\/10.1177\/1877718X261466810","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"3257_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB (2020) The genetic architecture of Parkinson\u2019s disease. Lancet Neurol 19(2):170\u2013178. https:\/\/doi.org\/10.1016\/S1474-4422(19)30287-X","journal-title":"Lancet Neurol"},{"issue":"3","key":"3257_CR20","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/mdc3.13660","volume":"10","author":"CK Block","year":"2023","unstructured":"Block CK, Patel M, Risk BB, Staikova E, Loring D, Esper CD, Scorr L, Higginbotham L, Aia P, DeLong MR, Wichmann T, Factor SA, Au Yong N, Willie JT, Boulis NM, Gross RE, Buetefisch C, Miocinovic S (2023) Patients with Cognitive Impairment in Parkinson\u2019s Disease Benefit from Deep Brain Stimulation: A Case-Control Study. Mov Disord Clin Pract 10(3):382\u2013391. https:\/\/doi.org\/10.1002\/mdc3.13660","journal-title":"Mov Disord Clin Pract"},{"issue":"7","key":"3257_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1474-4422(20)30064-8","volume":"19","author":"BR Bloem","year":"2020","unstructured":"Bloem BR, Henderson EJ, Dorsey ER, Okun MS, Okubadejo N, Chan P, Andrejack J, Darweesh SKL, Munneke M (2020) Integrated and patient-centred management of Parkinson\u2019s disease: a network model for reshaping chronic neurological care. Lancet Neurol 19(7):623\u2013634. https:\/\/doi.org\/10.1016\/S1474-4422(20)30064-8","journal-title":"Lancet Neurol"},{"issue":"22","key":"3257_CR22","doi-asserted-by":"publisher","first-page":"e2194","DOI":"10.1212\/WNL.0000000000200113","volume":"98","author":"MA Bock","year":"2022","unstructured":"Bock MA, Brown EG, Zhang L, Tanner C (2022) Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease. Neurology 98(22):e2194\u2013e2203. https:\/\/doi.org\/10.1212\/WNL.0000000000200113","journal-title":"Neurology"},{"issue":"Pt 6","key":"3257_CR24","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1093\/brain\/awq079","volume":"133","author":"NI Bohnen","year":"2010","unstructured":"Bohnen NI, M\u00fcller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA (2010) Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson\u2019s disease. Brain 133(Pt 6):1747\u20131754. https:\/\/doi.org\/10.1093\/brain\/awq079","journal-title":"Brain"},{"key":"3257_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/bs.irn.2018.07.027","volume":"141","author":"NI Bohnen","year":"2018","unstructured":"Bohnen NI, Kanel P, M\u00fcller M (2018) Molecular Imaging of the Cholinergic System in Parkinson\u2019s Disease. Int Rev Neurobiol 141:211\u2013250. https:\/\/doi.org\/10.1016\/bs.irn.2018.07.027","journal-title":"Int Rev Neurobiol"},{"key":"3257_CR25","doi-asserted-by":"publisher","first-page":"1258979","DOI":"10.3389\/fnagi.2023.1258979","volume":"15","author":"A Brooks","year":"2023","unstructured":"Brooks A (2023) Dysphagia and aspiration during a Parkinson\u2019s hospitalization: a care partner\u2019s perspective and recommendations for improving standards of care. Front Aging Neurosci 15:1258979. https:\/\/doi.org\/10.3389\/fnagi.2023.1258979","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"3257_CR26","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3233\/JPD-223433","volume":"13","author":"MC Brumm","year":"2023","unstructured":"Brumm MC, Siderowf A, Simuni T, Burghardt E, Choi SH, Caspell-Garcia C, Chahine LM, Mollenhauer B, Foroud T, Galasko D, Merchant K, Arnedo V, Hutten SJ, O\u2019Grady AN, Poston KL, Tanner CM, Weintraub D, Kieburtz K, Marek K, Coffey CS (2023) Parkinson\u2019s progression markers I Parkinson\u2019s progression markers initiative: a milestone-based strategy to monitor Parkinson\u2019s disease progression. J Parkinsons Dis 13(6):899\u2013916. https:\/\/doi.org\/10.3233\/JPD-223433","journal-title":"J Parkinsons Dis"},{"key":"3257_CR27","doi-asserted-by":"publisher","first-page":"107898","DOI":"10.1016\/j.parkreldis.2025.107898","volume":"137","author":"A Burade","year":"2025","unstructured":"Burade A, Dagher R, Kaviani P, Lakhani DA, Sair HI, Luna LP (2025) Comparative diagnostic efficacy of neuromelanin MRI vs. dopamine transporter (DAT) imaging in Parkinson\u2019s disease: A systematic review. Parkinsonism Relat Disord 137:107898. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107898","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"3257_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.7861\/clinmedicine.10-3-290","volume":"10","author":"CW Campbell","year":"2010","unstructured":"Campbell CW, Jones EJ, Merrills J (2010) Palliative and end-of-life care in advanced Parkinson\u2019s disease and multiple sclerosis. Clin Med (Lond) 10(3):290\u2013292. https:\/\/doi.org\/10.7861\/clinmedicine.10-3-290","journal-title":"Clin Med (Lond)"},{"key":"3257_CR29","doi-asserted-by":"publisher","first-page":"1494385","DOI":"10.3389\/fnagi.2024.1494385","volume":"16","author":"D Cao","year":"2024","unstructured":"Cao D, Yue J, Wei Z, Huang DH, Sun X, Liu KX, Wang P, Jiang F, Li X, Zhang Q (2024) Magnetic resonance imaging of brain structural and functional changes in cognitive impairment associated with Parkinson\u2019s disease. Front Aging Neurosci 16:1494385. https:\/\/doi.org\/10.3389\/fnagi.2024.1494385","journal-title":"Front Aging Neurosci"},{"key":"3257_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells15010042","author":"C Cattaneo","year":"2025","unstructured":"Cattaneo C, Fabbrini A, Belvisi D, Aiello F, Marchet F, Fabbrini G (2025) Non-motor symptoms: the hidden face of Parkinson\u2019s Disease. Cells. https:\/\/doi.org\/10.3390\/cells15010042","journal-title":"Cells"},{"issue":"1","key":"3257_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41746-022-00568-y","volume":"5","author":"AS Chandrabhatla","year":"2022","unstructured":"Chandrabhatla AS, Pomeraniec IJ, Ksendzovsky A (2022) Co-evolution of machine learning and digital technologies to improve monitoring of Parkinson\u2019s disease motor symptoms. NPJ Digit Med 5(1):32. https:\/\/doi.org\/10.1038\/s41746-022-00568-y","journal-title":"NPJ Digit Med"},{"key":"3257_CR32","doi-asserted-by":"publisher","first-page":"1617106","DOI":"10.3389\/fnagi.2025.1617106","volume":"17","author":"SA Chaudhary","year":"2025","unstructured":"Chaudhary SA, Chaudhary S, Rawat S (2025) Understanding Parkinson\u2019s disease: current trends and its multifaceted complications. Front Aging Neurosci 17:1617106. https:\/\/doi.org\/10.3389\/fnagi.2025.1617106","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"3257_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 5(3):235\u2013245","journal-title":"Lancet Neurol"},{"issue":"3","key":"3257_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1589\/jpts.29.457","volume":"29","author":"YI Choi","year":"2017","unstructured":"Choi YI, Song CS, Chun BY (2017) Activities of daily living and manual hand dexterity in persons with idiopathic parkinson disease. J Phys Ther Sci 29(3):457\u2013460. https:\/\/doi.org\/10.1589\/jpts.29.457","journal-title":"J Phys Ther Sci"},{"key":"3257_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-026-01481-7","author":"N Chunga","year":"2026","unstructured":"Chunga N, Reddy V, Barbosa W, Adams JL (2026) Digital Technologies for Symptom Monitoring in Parkinson Disease. Curr Neurol Neurosci Rep. https:\/\/doi.org\/10.1007\/s11910-026-01481-7","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"3257_CR36","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/ana.24777","volume":"80","author":"R Cilia","year":"2016","unstructured":"Cilia R, Tunesi S, Marotta G, Cereda E, Siri C, Tesei S, Zecchinelli AL, Canesi M, Mariani CB, Meucci N, Sacilotto G, Zini M, Barichella M, Magnani C, Duga S, Asselta R, Solda G, Seresini A, Seia M, Pezzoli G, Goldwurm S (2016) Survival and dementia in GBA-associated Parkinson\u2019s disease: The mutation matters. Ann Neurol 80(5):662\u2013673. https:\/\/doi.org\/10.1002\/ana.24777","journal-title":"Ann Neurol"},{"key":"3257_CR37","doi-asserted-by":"publisher","first-page":"103141","DOI":"10.1016\/j.conb.2025.103141","volume":"95","author":"G Cogan","year":"2025","unstructured":"Cogan G, Lesage S, Brice A (2025) The genetics of autosomal recessive early-onset Parkinson\u2019s disease. Curr Opin Neurobiol 95:103141. https:\/\/doi.org\/10.1016\/j.conb.2025.103141","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"3257_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12889-024-21236-8","volume":"25","author":"S Crooks","year":"2025","unstructured":"Crooks S, Mitchell G, Wynne L, Carter G (2025) Exploring the stigma experienced by people affected by Parkinson\u2019s disease: a systematic review. BMC Public Health 25(1):25. https:\/\/doi.org\/10.1186\/s12889-024-21236-8","journal-title":"BMC Public Health"},{"key":"3257_CR39","doi-asserted-by":"publisher","first-page":"1805627","DOI":"10.3389\/fnagi.2026.1805627","volume":"18","author":"L Culicetto","year":"2026","unstructured":"Culicetto L, Bonanno L, Monea G, Marafioti G, Giambo FM, Di Lorenzo G, Vicario CM, Salehinejad MA, Quartarone A, Marino S, Lo Buono V (2026) Determinants of caregiver burden in advanced Parkinson\u2019s disease: a multidimensional and sex-sensitive perspective. Front Aging Neurosci 18:1805627. https:\/\/doi.org\/10.3389\/fnagi.2026.1805627","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"3257_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s43856-024-00481-3","volume":"4","author":"MD Czech","year":"2024","unstructured":"Czech MD, Badley D, Yang L, Shen J, Crouthamel M, Kangarloo T, Dorsey ER, Adams JL, Cosman JD (2024) Improved measurement of disease progression in people living with early Parkinson\u2019s disease using digital health technologies. Commun Med (Lond) 4(1):49. https:\/\/doi.org\/10.1038\/s43856-024-00481-3","journal-title":"Commun Med (Lond)"},{"issue":"1","key":"3257_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s42466-024-00309-4","volume":"6","author":"C Daniels","year":"2024","unstructured":"Daniels C, Rodr\u00edguez-Antig\u00fcedad J, Jentschke E, Kulisevsky J, Volkmann J (2024) Cognitive disorders in advanced Parkinson\u2019s disease: challenges in the diagnosis of delirium. Neurol Res Pract 6(1):14. https:\/\/doi.org\/10.1186\/s42466-024-00309-4","journal-title":"Neurol Res Pract"},{"issue":"5","key":"3257_CR42","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/mds.30162","volume":"40","author":"RMA de Bie","year":"2025","unstructured":"de Bie RMA, Katzenschlager R, Swinnen B, Peball M, Lim SY, Mestre TA, Perez Lloret S, Coelho M, Aquino C, Tan AH, Bruno V, Dijk JM, Heim B, Lin CH, Kauppila LA, Litvan I, Spijker R, Seppi K, Costa J, Sampaio C, Fox SH, Silverdale MA (2025) Update on Treatments for Parkinson\u2019s Disease Motor Fluctuations - An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review. Mov Disord 40(5):776\u2013794. https:\/\/doi.org\/10.1002\/mds.30162","journal-title":"Mov Disord"},{"issue":"3","key":"3257_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.14802\/jmd.25045","volume":"18","author":"APR De Leon","year":"2025","unstructured":"De Leon APR, Bhidayasiri R, Phokaewvarangkul O (2025) Optimizing Device-Aided Therapies in Advanced Parkinson\u2019s Disease: A Case Series on Continuous Subcutaneous Apomorphine Infusion in Challenging Scenarios. J Mov Disord 18(3):285\u2013288. https:\/\/doi.org\/10.14802\/jmd.25045","journal-title":"J Mov Disord"},{"issue":"5","key":"3257_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/mdc3.12795","volume":"6","author":"LM de Oliveira","year":"2019","unstructured":"de Oliveira LM, Barbosa ER, Aquino CC, Munhoz RP, Fasano A, Cury RG (2019) Deep Brain Stimulation in Patients With Mutations in Parkinson\u2019s Disease-Related Genes: A Systematic Review. Mov Disord Clin Pract 6(5):359\u2013368. https:\/\/doi.org\/10.1002\/mdc3.12795","journal-title":"Mov Disord Clin Pract"},{"key":"3257_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14040397","author":"S Diaconu","year":"2024","unstructured":"Diaconu S, Monescu V, Filip R, Marian L, Kakucs C, Murasan I, Chaudhuri KR, Jianu DC, Falup-Pecurariu C, Opritoiu B (2024) The impact of fatigue on sleep and other non-motor symptoms in Parkinson\u2019s disease. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci14040397","journal-title":"Brain Sci"},{"issue":"6","key":"3257_CR46","doi-asserted-by":"publisher","first-page":"e14280","DOI":"10.1111\/nmo.14280","volume":"34","author":"S Dilmaghani","year":"2022","unstructured":"Dilmaghani S, Atieh J, Khanna L, Hosfield EA, Camilleri M, Katzka DA (2022) Severity of dysphagia is associated with hospitalizations and mortality in patients with Parkinson\u2019s disease. Neurogastroenterol Motil 34(6):e14280. https:\/\/doi.org\/10.1111\/nmo.14280","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"3257_CR47","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/mdc3.70517","volume":"13","author":"S Dorrance","year":"2026","unstructured":"Dorrance S, Patel R, Stebbins GT, Adams JL, Allen AM, Hastings T, Mathur S, Phokaewvarangkul O, Rafaloff G, Rajalingam R, Schrag A, Sun C, Mammen J, Marras C (2026) Defining Quality of Life: The Perspective of People Living with Parkinson\u2019s Disease. Mov Disord Clin Pract 13(6):1446\u20131451. https:\/\/doi.org\/10.1002\/mdc3.70517","journal-title":"Mov Disord Clin Pract"},{"issue":"14","key":"3257_CR48","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1001\/jama.1960.03020320060017","volume":"173","author":"HF Dowling","year":"1960","unstructured":"Dowling HF (1960) WHAT\u2019S IN A NAME? JAMA 173(14):1580\u20131582. https:\/\/doi.org\/10.1001\/jama.1960.03020320060017","journal-title":"JAMA"},{"key":"3257_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12010089","author":"HV Eichel","year":"2022","unstructured":"Eichel HV, Heine J, Wegner F, Rogozinski S, Stiel S, Groh A, Krey L, H\u00f6glinger GU, Klietz M (2022) Neuropsychiatric symptoms in Parkinson\u2019s disease patients are associated with reduced health-related quality of life and increased caregiver burden. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci12010089","journal-title":"Brain Sci"},{"key":"3257_CR50","doi-asserted-by":"publisher","first-page":"107317","DOI":"10.1016\/j.parkreldis.2025.107317","volume":"133","author":"JA Elbek","year":"2025","unstructured":"Elbek JA, N\u00f8rgaard B, Pedersen T, Thuesen J (2025) Non-pharmacological rehabilitation for people living with advanced Parkinson\u2019s disease: A scoping review of interventions. Parkinsonism Relat Disord 133:107317. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107317","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"3257_CR52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/jpd-2011-0002","volume":"1","author":"JR Evans","year":"2011","unstructured":"Evans JR, Mason SL, Williams-Gray CH, Foltynie T, Trotter M, Barker RA (2011) The factor structure of the UPDRS as an index of disease progression in Parkinson\u2019s disease. J Parkinsons Dis 1(1):75\u201382. https:\/\/doi.org\/10.3233\/jpd-2011-0002","journal-title":"J Parkinsons Dis"},{"key":"3257_CR51","doi-asserted-by":"publisher","first-page":"100075","DOI":"10.1016\/j.prdoa.2020.100075","volume":"4","author":"A Evans","year":"2021","unstructured":"Evans A, Fung VSC, O\u2019Sullivan JD, Stell R, White R, Williams DR, Femia S, Onuk K (2021) Characteristics of advanced Parkinson\u2019s disease patients seen in movement disorder clinics - Australian results from the cross-sectional OBSERVE study. Clin Park Relat Disord 4:100075. https:\/\/doi.org\/10.1016\/j.prdoa.2020.100075","journal-title":"Clin Park Relat Disord"},{"key":"3257_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12050813","author":"M Fabbri","year":"2022","unstructured":"Fabbri M, Coelho M, Garon M, Biundo R, Mestre TA, Antonini A, On Behalf Of i C-PC (2022) Personalized care in late-stage Parkinson\u2019s disease: challenges and opportunities. J Pers Med. https:\/\/doi.org\/10.3390\/jpm12050813","journal-title":"J Pers Med"},{"issue":"1","key":"3257_CR54","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/acn3.50961","volume":"7","author":"SY Fan","year":"2020","unstructured":"Fan SY, Wang KL, Hu W, Eisinger RS, Han A, Han CL, Wang Q, Michitomo S, Zhang JG, Wang F, Ramirez-Zamora A, Meng FG (2020) Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia. Ann Clin Transl Neurol 7(1):59\u201368. https:\/\/doi.org\/10.1002\/acn3.50961","journal-title":"Ann Clin Transl Neurol"},{"key":"3257_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12730-5","author":"A Fanciulli","year":"2025","unstructured":"Fanciulli A, Sixel-Doring F, Buhmann C, Krismer F, Hermann W, Winkler C, Woitalla D, Jost WH, German Parkinson\u2019s, Guideline G, Trenkwalder C, Hoglinger G (2025) Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson\u2019s disease: guideline Parkinson\u2019s disease of the German Society of Neurology. J Neurol 272 (1):90. https:\/\/doi.org\/10.1007\/s00415-024-12730-5","journal-title":"J Neurol"},{"issue":"Suppl 1","key":"3257_CR56","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.21037\/apm.2019.09.12","volume":"9","author":"JE Fleisher","year":"2020","unstructured":"Fleisher JE, Klostermann EC, Hess SP, Lee J, Myrick E, Chodosh J (2020) Interdisciplinary palliative care for people with advanced Parkinson\u2019s disease: a view from the home. Ann Palliat Med 9(Suppl 1):S80\u2013S89. https:\/\/doi.org\/10.21037\/apm.2019.09.12","journal-title":"Ann Palliat Med"},{"key":"3257_CR57","doi-asserted-by":"publisher","first-page":"100240","DOI":"10.1016\/j.prdoa.2024.100240","volume":"10","author":"M Gandolfi","year":"2024","unstructured":"Gandolfi M, Geroin C, Imbalzano G, Camozzi S, Menaspa Z, Tinazzi M, Alberto Artusi C (2024) Treatment of axial postural abnormalities in parkinsonism disorders: A systematic review of pharmacological, rehabilitative and surgical interventions. Clin Park Relat Disord 10:100240. https:\/\/doi.org\/10.1016\/j.prdoa.2024.100240","journal-title":"Clin Park Relat Disord"},{"issue":"3","key":"3257_CR58","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/mds.870100305","volume":"10","author":"CG Goetz","year":"1995","unstructured":"Goetz CG, Stebbins GT, Chmura TA, Fahn S, Klawans HL, Marsden CD (1995) Teaching tape for the motor section of the unified Parkinson\u2019s disease rating scale. Mov Disord 10(3):263\u2013266. https:\/\/doi.org\/10.1002\/mds.870100305","journal-title":"Mov Disord"},{"issue":"15","key":"3257_CR59","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG van Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2008) Movement Disorder Society URTF Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129\u20132170. https:\/\/doi.org\/10.1002\/mds.22340","journal-title":"Mov Disord"},{"issue":"12","key":"3257_CR60","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41582-024-01033-y","volume":"20","author":"MH Gramkow","year":"2024","unstructured":"Gramkow MH, Waldemar G, Frederiksen KS (2024) The Digitized Memory Clinic. Nat Rev Neurol 20(12):738\u2013746. https:\/\/doi.org\/10.1038\/s41582-024-01033-y","journal-title":"Nat Rev Neurol"},{"key":"3257_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-026-03208-x","author":"S Groppa","year":"2026","unstructured":"Groppa S, Fasano A, Urso D, Yang X, Popescu B, Klivenyi P, van Laar T, Jost W, Garcia-Ruiz PJ, Bhidayasiri R, Outeiro TF (2026) Disease modification in advanced Parkinson\u2019s disease: a review and roadmap for paving the way for next-generation interventions. J Neural Transm (Vienna). https:\/\/doi.org\/10.1007\/s00702-026-03208-x","journal-title":"J Neural Transm (Vienna)"},{"key":"3257_CR62","doi-asserted-by":"publisher","first-page":"175628642513560","DOI":"10.1177\/17562864251356062","volume":"18","author":"B Heim","year":"2025","unstructured":"Heim B, Djamshidian A (2025) Neuropsychiatric disorders in Parkinson\u2019s disease. Ther Adv Neurol Disord 18:17562864251356062. https:\/\/doi.org\/10.1177\/17562864251356062","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"3257_CR63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/jcm15010063","volume":"15","author":"D Hern\u00e1ndez-Triana","year":"2026","unstructured":"Hern\u00e1ndez-Triana D, P\u00e1ez-Garc\u00eda S, Mena A, Gimeno M, Soto-Leal A, Rodriguez-Oroz MC, Borda MG (2026) Parkinson\u2019s Disease and Frailty: A Two-Way Link Across Aging. J Clin Med 15(1):63. https:\/\/doi.org\/10.3390\/jcm15010063","journal-title":"J Clin Med"},{"issue":"1","key":"3257_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11910-025-01470-2","volume":"26","author":"J Hickman","year":"2025","unstructured":"Hickman J, Tsai A, Fullard M, Korsmo M, Forbes E, Aslam S, Baumgartner AJ, Feuerstein JS, Bayram E (2025) Early-Onset Parkinson\u2019s Disease: Unique Features and Management Approaches. Curr Neurol Neurosci Rep 26(1):3. https:\/\/doi.org\/10.1007\/s11910-025-01470-2","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"3257_CR65","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427\u2013442","journal-title":"Neurology"},{"issue":"2","key":"3257_CR66","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU Hoglinger","year":"2024","unstructured":"Hoglinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W, Postuma R, Stoessl AJ, Lang AE (2024) A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol 23(2):191\u2013204. https:\/\/doi.org\/10.1016\/S1474-4422(23)00404-0","journal-title":"Lancet Neurol"},{"key":"3257_CR67","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.parkreldis.2022.10.012","volume":"104","author":"A Hommel","year":"2022","unstructured":"Hommel A, Krijthe JH, Darweesh S, Bloem BR (2022) The association of comorbidity with Parkinson\u2019s disease-related hospitalizations. Parkinsonism Relat Disord 104:123\u2013128. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.10.012","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"3257_CR68","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/ene.15558","volume":"30","author":"G Imbalzano","year":"2023","unstructured":"Imbalzano G, Rinaldi D, Calandra-Buonaura G, Contin M, Amato F, Giannini G, Sambati L, Ledda C, Romagnolo A, Olmo G, Cortelli P, Zibetti M, Lopiano L, Artusi CA (2023) How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease. Eur J Neurol 30(1):96\u2013106. https:\/\/doi.org\/10.1111\/ene.15558","journal-title":"Eur J Neurol"},{"key":"3257_CR69","unstructured":"International Classification of Functioning, Disability, and, Health, ICF) (2001) (World Health Organization, Geneva, Switzerland"},{"key":"3257_CR70","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/PROM.S243990","volume":"11","author":"P Jagota","year":"2020","unstructured":"Jagota P, Jongsuntisuk P, Plengsri R, Chokpatcharavate M, Phokaewvarangkul O, Chirapravati V, Panyakaew P, Sringean J, Bhidayasiri R (2020) If Your Patients Were Too Embarrassed to Go Out in Public, What Would You Do? - Public Education to Break the Stigma on Parkinson\u2019s Disease Using Integrated Media. Patient Relat Outcome Meas 11:143\u2013148. https:\/\/doi.org\/10.2147\/PROM.S243990","journal-title":"Patient Relat Outcome Meas"},{"key":"3257_CR71","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40734-016-0043-x","volume":"3","author":"O Jitkritsadakul","year":"2016","unstructured":"Jitkritsadakul O, Bhidayasiri R (2016) Physicians\u2019 role in the determination of fitness to drive in patients with Parkinson\u2019s disease: systematic review of the assessment tools and a call for national guidelines. J Clin Mov Disord 3:14. https:\/\/doi.org\/10.1186\/s40734-016-0043-x","journal-title":"J Clin Mov Disord"},{"issue":"9","key":"3257_CR73","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/mds.25347","volume":"28","author":"O Jitkritsadakul","year":"2013","unstructured":"Jitkritsadakul O, Jagota P, Petchrutchatachart S, Sansopha L, Rerknimitr R, Bhidayasiri R (2013) Recurrent pancreatitis as a rare complication of duodenal levodopa infusion treatment. Mov Disord 28(9):1308\u20131310. https:\/\/doi.org\/10.1002\/mds.25347","journal-title":"Mov Disord"},{"issue":"5","key":"3257_CR72","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.brs.2017.07.003","volume":"10","author":"O Jitkritsadakul","year":"2017","unstructured":"Jitkritsadakul O, Bhidayasiri R, Kalia SK, Hodaie M, Lozano AM, Fasano A (2017) Systematic review of hardware-related complications of Deep Brain Stimulation: Do new indications pose an increased risk? Brain Stimul 10(5):967\u2013976. https:\/\/doi.org\/10.1016\/j.brs.2017.07.003","journal-title":"Brain Stimul"},{"issue":"11","key":"3257_CR74","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00702-023-02733-3","volume":"131","author":"WH Jost","year":"2024","unstructured":"Jost WH (2024) Advanced is advanced is advanced is advanced. J Neural Transm 131(11):1275\u20131276. https:\/\/doi.org\/10.1007\/s00702-023-02733-3","journal-title":"J Neural Transm"},{"issue":"5","key":"3257_CR75","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/mds.27352","volume":"33","author":"M Kasten","year":"2018","unstructured":"Kasten M, Hartmann C, Hampf J, Schaake S, Westenberger A, Vollstedt EJ, Balck A, Domingo A, Vulinovic F, Dulovic M, Zorn I, Madoev H, Zehnle H, Lembeck CM, Schawe L, Reginold J, Huang J, Konig IR, Bertram L, Marras C, Lohmann K, Lill CM, Klein C (2018) Genotype-Phenotype Relations for the Parkinson\u2019s Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review. Mov Disord 33(5):730\u2013741. https:\/\/doi.org\/10.1002\/mds.27352","journal-title":"Mov Disord"},{"key":"3257_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2023.10.009","author":"MY Kim","year":"2023","unstructured":"Kim MY, Jethani P, Kang E, Lipsey KL, Foster ER (2023) Conceptualization, Measurement, and Factors Associated with Participation in Parkinson\u2019s Disease: A Systematic Review and Qualitative Analysis. Arch Phys Med Rehabil. https:\/\/doi.org\/10.1016\/j.apmr.2023.10.009","journal-title":"Arch Phys Med Rehabil"},{"key":"3257_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-026-03167-3","author":"T Koeglsperger","year":"2026","unstructured":"Koeglsperger T, Hollerhage M, Kassubek J, Woitalla D, Winkler J, Klucken J (2026) The future digital outpatient clinic for movement disorders: from technological innovation to ethical and systemic implementation-a position paper. J Neural Transm (Vienna). https:\/\/doi.org\/10.1007\/s00702-026-03167-3","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"3257_CR78","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-025-00881-9","volume":"11","author":"C Kruger","year":"2025","unstructured":"Kruger C, Lim SY, Buhrmann A, Fahrig FL, Gabbert C, Bahr N, Madoev H, Marras C, Klein C, Lohmann K (2025) Updated MDSGene review on the clinical and genetic spectrum of LRRK2 variants in Parkinson s disease. NPJ Parkinsons Dis 11(1):30. https:\/\/doi.org\/10.1038\/s41531-025-00881-9","journal-title":"NPJ Parkinsons Dis"},{"issue":"5","key":"3257_CR79","doi-asserted-by":"publisher","first-page":"909","DOI":"10.4103\/aian.aian_647_21","volume":"25","author":"A Kumar","year":"2022","unstructured":"Kumar A, Patil S, Singh VK, Pathak A, Chaurasia RN, Mishra VN, Joshi D (2022) Assessment of Non-Motor Symptoms of Parkinson\u2019s Disease and Their Impact on the Quality of Life: An Observatiobnal Study. Ann Indian Acad Neurol 25(5):909\u2013915. https:\/\/doi.org\/10.4103\/aian.aian_647_21","journal-title":"Ann Indian Acad Neurol"},{"key":"3257_CR80","doi-asserted-by":"publisher","first-page":"100458","DOI":"10.1016\/j.prdoa.2026.100458","volume":"14","author":"D Ledingham","year":"2026","unstructured":"Ledingham D, Stewart CB, Sathyanarayana S, Foster V, Iredale R, Galley D, Baker MR, Pavese N (2026) Timing of device-aided therapy initiation in Parkinson\u2019s disease: reference estimates for healthcare planning and biological heterogeneity. Clin Parkinsonism Relat Disorders 14:100458. https:\/\/doi.org\/10.1016\/j.prdoa.2026.100458","journal-title":"Clin Parkinsonism Relat Disorders"},{"issue":"Suppl 1","key":"3257_CR81","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.3109\/09638280903317732","volume":"31","author":"M Leonardi","year":"2009","unstructured":"Leonardi M, Meucci P, Ajovalasit D, Albanesi F, Cerniauskaite M, Invernizzi V, Lembo R, Quintas R, Sattin D, Carella F, Romito L, Soliveri P, Bussone G, D\u2019Amico D, Maggi L, Mantegazza R, Raggi A (2009) ICF in neurology: functioning and disability in patients with migraine, myasthenia gravis and Parkinson\u2019s disease. Disabil Rehabil 31(Suppl 1):S88\u201399. https:\/\/doi.org\/10.3109\/09638280903317732","journal-title":"Disabil Rehabil"},{"key":"3257_CR82","doi-asserted-by":"publisher","first-page":"1624203","DOI":"10.3389\/fnagi.2025.1624203","volume":"17","author":"G Li","year":"2025","unstructured":"Li G, Zhang W, Mao F, Zhao H, Zhao L, Yang Y, Sun C, Liu L, Wang X, Luo X (2025a) (18)F-FDG PET\/MR reveals specific brain metabolic features in Parkinson\u2019s disease with frailty. Front Aging Neurosci 17:1624203. https:\/\/doi.org\/10.3389\/fnagi.2025.1624203","journal-title":"Front Aging Neurosci"},{"key":"3257_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1671760","author":"Q Li","year":"2025","unstructured":"Li Q, Bi Z, Liang W, Yin S, Li H, Liang Z, Wu M, Quan J, Li C (2025b) Effects of glucocerebrosidase gene variations on the risk of Parkinson\u2019s disease dementia: a meta-analysis. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2025.1671760","journal-title":"Front Aging Neurosci"},{"key":"3257_CR84","doi-asserted-by":"publisher","first-page":"e85596","DOI":"10.2196\/85596","volume":"28","author":"S Li","year":"2026","unstructured":"Li S, Chen S, Yu X, Shang H, Tu T, Quan M (2026) AI-Enabled Wearables for Motor Function Assessment and Rehabilitation in Parkinson Disease: Scoping Review. J Med Internet Res 28:e85596. https:\/\/doi.org\/10.2196\/85596","journal-title":"J Med Internet Res"},{"issue":"12","key":"3257_CR85","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S1474-4422(24)00378-8","volume":"23","author":"SY Lim","year":"2024","unstructured":"Lim SY, Tan AH, Ahmad-Annuar A, Okubadejo NU, Lohmann K, Morris HR, Toh TS, Tay YW, Lange LM, Bandres-Ciga S, Mata I, Foo JN, Sammler E, Ooi JCE, Noyce AJ, Bahr N, Luo W, Ojha R, Singleton AB, Blauwendraat C, Klein C (2024) Uncovering the genetic basis of Parkinson\u2019s disease globally: from discoveries to the clinic. Lancet Neurol 23(12):1267\u20131280. https:\/\/doi.org\/10.1016\/S1474-4422(24)00378-8","journal-title":"Lancet Neurol"},{"issue":"1","key":"3257_CR86","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12916-023-03120-1","volume":"21","author":"J Lin","year":"2023","unstructured":"Lin J, Ou R, Li C, Hou Y, Zhang L, Wei Q, Pang D, Liu K, Jiang Q, Yang T, Xiao Y, Zhao B, Chen X, Song W, Yang J, Wu Y, Shang H (2023) Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson\u2019s disease: a prospective cohort study. BMC Med 21(1):420. https:\/\/doi.org\/10.1186\/s12916-023-03120-1","journal-title":"BMC Med"},{"issue":"1","key":"3257_CR87","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-023-02843-5","volume":"20","author":"T Liu","year":"2023","unstructured":"Liu T, Zuo H, Ma D, Song D, Zhao Y, Cheng O (2023) Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer\u2019s disease-associated biomarkers alterations among de novo Parkinson\u2019s disease patients: a prospective cohort study. J Neuroinflammation 20(1):167. https:\/\/doi.org\/10.1186\/s12974-023-02843-5","journal-title":"J Neuroinflammation"},{"key":"3257_CR88","doi-asserted-by":"publisher","first-page":"4047392","DOI":"10.1155\/2017\/4047392","volume":"2017","author":"MR Luquin","year":"2017","unstructured":"Luquin MR, Kulisevsky J, Martinez-Martin P, Mir P, Tolosa ES (2017) Consensus on the Definition of Advanced Parkinson\u2019s Disease: A Neurologists-Based Delphi Study (CEPA Study). Parkinsons Dis 2017:4047392. https:\/\/doi.org\/10.1155\/2017\/4047392","journal-title":"Parkinsons Dis"},{"key":"3257_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2018.00001","volume":"10","author":"K Ma","year":"2018","unstructured":"Ma K, Xiong N, Shen Y, Han C, Liu L, Zhang G, Wang L, Guo S, Guo X, Xia Y, Wan F, Huang J, Lin Z, Wang T (2018) Weight Loss and Malnutrition in Patients with Parkinson\u2019s Disease: Current Knowledge and Future Prospects. Front Aging Neurosci 10:1. https:\/\/doi.org\/10.3389\/fnagi.2018.00001","journal-title":"Front Aging Neurosci"},{"key":"3257_CR90","doi-asserted-by":"publisher","first-page":"106039","DOI":"10.1016\/j.parkreldis.2024.106039","volume":"122","author":"G Maayan Eshed","year":"2024","unstructured":"Maayan Eshed G, Alcalay RN (2024) GBA1-and LRRK2-directed Treatments: The Way Forward. Parkinsonism Relat Disord 122:106039. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106039","journal-title":"Parkinsonism Relat Disord"},{"key":"3257_CR91","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28377","author":"W Maetzler","year":"2020","unstructured":"Maetzler W, Rochester L, Bhidayasiri R, Espay AJ, Sanchez-Ferro A, van Uem JMT (2020) Modernizing Daily Function Assessment in Parkinson\u2019s Disease Using Capacity, Perception, and Performance Measures. Mov Disord. https:\/\/doi.org\/10.1002\/mds.28377","journal-title":"Mov Disord"},{"issue":"1","key":"3257_CR92","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10072-023-06999-z","volume":"45","author":"M Mainardi","year":"2024","unstructured":"Mainardi M, Ciprietti D, Pilleri M, Bonato G, Weis L, Cianci V, Biundo R, Ferreri F, Piacentino M, Landi A, Guerra A, Antonini A (2024) Deep brain stimulation of globus pallidus internus and subthalamic nucleus in Parkinson\u2019s disease: a multicenter, retrospective study of efficacy and safety. Neurol Sci 45(1):177\u2013185. https:\/\/doi.org\/10.1007\/s10072-023-06999-z","journal-title":"Neurol Sci"},{"issue":"1","key":"3257_CR93","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12883-022-02560-1","volume":"22","author":"IA Malaty","year":"2022","unstructured":"Malaty IA, Martinez-Martin P, Chaudhuri KR, Odin P, Skorvanek M, Jimenez-Shahed J, Soileau MJ, Lindvall S, Domingos J, Jones S, Alobaidi A, Jalundhwala YJ, Kandukuri PL, Onuk K, Bergmann L, Femia S, Lee MY, Wright J, Antonini A (2022) Does the 5-2-1 criteria identify patients with advanced Parkinson\u2019s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries. BMC Neurol 22(1):35. https:\/\/doi.org\/10.1186\/s12883-022-02560-1","journal-title":"BMC Neurol"},{"key":"3257_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11121557","author":"JC Mart\u00ednez-Castrillo","year":"2021","unstructured":"Mart\u00ednez-Castrillo JC, Mart\u00ednez-Mart\u00edn P, Burgos \u00c1, Arroyo G, Garc\u00eda N, Luqu\u00edn MR, Arbelo JM (2021) Prevalence of advanced Parkinson\u2019s Disease in patients treated in the hospitals of the Spanish national healthcare system: The PARADISE Study. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci11121557","journal-title":"Brain Sci"},{"issue":"4","key":"3257_CR95","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1007\/s00415-022-11546-5","volume":"270","author":"P Martinez-Martin","year":"2023","unstructured":"Martinez-Martin P, Skorvanek M, Henriksen T, Lindvall S, Domingos J, Alobaidi A, Kandukuri PL, Chaudhari VS, Patel AB, Parra JC, Pike J, Antonini A (2023) Impact of advanced Parkinson\u2019s disease on caregivers: an international real-world study. J Neurol 270(4):2162\u20132173. https:\/\/doi.org\/10.1007\/s00415-022-11546-5","journal-title":"J Neurol"},{"key":"3257_CR96","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fneur.2012.00066","volume":"3","author":"J Massano","year":"2012","unstructured":"Massano J, Garrett C (2012) Deep brain stimulation and cognitive decline in Parkinson\u2019s disease: a clinical review. Front Neurol 3:66. https:\/\/doi.org\/10.3389\/fneur.2012.00066","journal-title":"Front Neurol"},{"issue":"6","key":"3257_CR97","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1474-4422(26)00090-6","volume":"25","author":"E Menozzi","year":"2026","unstructured":"Menozzi E, Toffoli M, Deleidi M, Di Monte DA, Blandini F, Krainc D, Sidransky E, Schapira AHV (2026) New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson\u2019s disease: prospects for treatment. Lancet Neurol 25(6):602\u2013614. https:\/\/doi.org\/10.1016\/S1474-4422(26)00090-6","journal-title":"Lancet Neurol"},{"key":"3257_CR98","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-026-03185-1","author":"SO Mittal","year":"2026","unstructured":"Mittal SO, Jost WH (2026) Beyond Advanced: proposing Fluctuation-Dominant Parkinson\u2019s disease as a functional alternative to enable timely device-aided therapy. J Neural Transm (Vienna). https:\/\/doi.org\/10.1007\/s00702-026-03185-1","journal-title":"J Neural Transm (Vienna)"},{"key":"3257_CR99","doi-asserted-by":"publisher","first-page":"1794132","DOI":"10.3389\/fneur.2026.1794132","volume":"17","author":"S Okusa","year":"2026","unstructured":"Okusa S, Tezuka T, Nukariya T, Nihei Y, Nakahara J, Seki M (2026) Discrepancies in symptom concerns and burden from the perspectives of parkinson\u2019s disease patients, caregivers, and physicians. Front Neurol 17:1794132. https:\/\/doi.org\/10.3389\/fneur.2026.1794132","journal-title":"Front Neurol"},{"key":"3257_CR100","doi-asserted-by":"publisher","first-page":"108064","DOI":"10.1016\/j.parkreldis.2025.108064","volume":"140","author":"HSD Oliveira","year":"2025","unstructured":"Oliveira HSD, Camargos ST, Cardoso F, Caramelli P (2025) Visuospatial impairment in Parkinson\u2019s Disease: why we should keep an eye on it. Parkinsonism Relat Disord 140:108064. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.108064","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"3257_CR101","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S1474-4422(25)00157-7","volume":"24","author":"CD Orru","year":"2025","unstructured":"Orru CD, Vaughan DP, Vijiaratnam N, Real R, Martinez-Carrasco A, Fumi R, Jensen MT, Hodgson M, Girges C, Gil-Martinez AL, Stafford EJ, Wu L, Lerche S, Wurster I, Groveman BR, Hughson AG, Ansorge O, Quaegebeur A, Allinson KSJ, Warner TT, Jaunmuktane Z, Misbahuddin A, Leigh PN, Ghosh BCP, Bhatia KP, Church A, Kobylecki C, Hu MTM, Rowe JB, Parchi P, Brockmann K, Foltynie T, Morris HR, Caughey B, Jabbari E (2025) Diagnostic and prognostic value of alpha-synuclein seed amplification assay kinetic measures in Parkinson\u2019s disease: a longitudinal cohort study. Lancet Neurol 24(7):580\u2013590. https:\/\/doi.org\/10.1016\/S1474-4422(25)00157-7","journal-title":"Lancet Neurol"},{"issue":"1","key":"3257_CR102","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41531-024-00758-3","volume":"10","author":"C Owens-Walton","year":"2024","unstructured":"Owens-Walton C, Nir TM, Al-Bachari S, Ambrogi S, Anderson TJ, Aventurato IK, Cendes F, Chen YL, Ciullo V, Cook P, Dalrymple-Alford JC, Dirkx MF, Druzgal J, Emsley HCA, Guimaraes R, Haroon HA, Helmich RC, Hu MT, Johansson ME, Kim HB, Klein JC, Laansma M, Lawrence KE, Lochner C, Mackay C, McMillan CT, Melzer TR, Nabulsi L, Newman B, Opriessnig P, Parkes LM, Pellicano C, Piras F, Piras F, Pirpamer L, Pitcher TL, Poston KL, Roos A, Silva LS, Schmidt R, Schwingenschuh P, Shahid-Besanti M, Spalletta G, Stein DJ, Thomopoulos SI, Tosun D, Tsai CC, van den Heuvel OA, van Heese E, Vecchio D, Villalon-Reina JE, Vriend C, Wang JJ, Wu YR, Yasuda CL, Thompson PM, Jahanshad N, van der Werf Y (2024) A worldwide study of white matter microstructural alterations in people living with Parkinson\u2019s disease. NPJ Parkinsons Dis 10(1):151. https:\/\/doi.org\/10.1038\/s41531-024-00758-3","journal-title":"NPJ Parkinsons Dis"},{"key":"3257_CR103","doi-asserted-by":"publisher","first-page":"100439","DOI":"10.1016\/j.prdoa.2026.100439","volume":"14","author":"MN Pacheco","year":"2026","unstructured":"Pacheco MN, Uribe C, Brown J, Jones JD (2026) Income, employment, and clinical outcomes in Parkinson\u2019s disease. Clin Park Relat Disord 14:100439. https:\/\/doi.org\/10.1016\/j.prdoa.2026.100439","journal-title":"Clin Park Relat Disord"},{"issue":"3","key":"3257_CR104","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.26302","volume":"91","author":"G Pal","year":"2022","unstructured":"Pal G, Mangone G, Hill EJ, Ouyang B, Liu Y, Lythe V, Ehrlich D, Saunders-Pullman R, Shanker V, Bressman S, Alcalay RN, Garcia P, Marder KS, Aasly J, Mouradian MM, Link S, Rosenbaum M, Anderson S, Bernard B, Wilson R, Stebbins G, Nichols WC, Welter ML, Sani S, Afshari M, Verhagen L, de Bie RMA, Foltynie T, Hall D, Corvol JC, Goetz CG (2022) Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers. Ann Neurol 91(3):424\u2013435. https:\/\/doi.org\/10.1002\/ana.26302","journal-title":"Ann Neurol"},{"key":"3257_CR105","doi-asserted-by":"publisher","first-page":"1452741","DOI":"10.3389\/fneur.2024.1452741","volume":"15","author":"A Pauwels","year":"2024","unstructured":"Pauwels A, Phan ALG, Ding C, Phan TG, Kempster PA (2024) Rate of motor progression in Parkinson\u2019s disease: a systematic review and meta-analysis. Front Neurol 15:1452741. https:\/\/doi.org\/10.3389\/fneur.2024.1452741","journal-title":"Front Neurol"},{"issue":"1","key":"3257_CR106","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41531-024-00768-1","volume":"10","author":"CC Pedersen","year":"2024","unstructured":"Pedersen CC, Ushakova A, Alves G, Tysnes OB, Blennow K, Zetterberg H, Maple-Grodem J, Lange J (2024) Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson\u2019s Disease. NPJ Parkinsons Dis 10(1):162. https:\/\/doi.org\/10.1038\/s41531-024-00768-1","journal-title":"NPJ Parkinsons Dis"},{"issue":"4","key":"3257_CR107","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s13311-020-00897-4","volume":"17","author":"RF Pfeiffer","year":"2020","unstructured":"Pfeiffer RF (2020) Autonomic Dysfunction in Parkinson\u2019s Disease. Neurotherapeutics 17(4):1464\u20131479. https:\/\/doi.org\/10.1007\/s13311-020-00897-4","journal-title":"Neurotherapeutics"},{"issue":"11","key":"3257_CR108","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00702-024-02782-2","volume":"131","author":"O Phokaewvarangkul","year":"2024","unstructured":"Phokaewvarangkul O, Auffret M, Groppa S, Markovic V, Petrovic I, Bhidayasiri R (2024) What was first and what is next in selecting device-aided therapy in Parkinson\u2019s disease? Balancing evidence and experience. J Neural Transm (Vienna) 131(11):1307\u20131320. https:\/\/doi.org\/10.1007\/s00702-024-02782-2","journal-title":"J Neural Transm (Vienna)"},{"issue":"11","key":"3257_CR109","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00702-025-02935-x","volume":"132","author":"O Phokaewvarangkul","year":"2025","unstructured":"Phokaewvarangkul O, Markaki I, Moes HR, Petrovic I, Schrag A, Bhidayasiri R (2025a) Vital nutrition: enhancing health in advanced Parkinson\u2019s disease with device-aided therapies. J Neural Transm (Vienna) 132(11):1685\u20131697. https:\/\/doi.org\/10.1007\/s00702-025-02935-x","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"3257_CR110","doi-asserted-by":"publisher","first-page":"26212","DOI":"10.1038\/s41598-025-09444-7","volume":"15","author":"O Phokaewvarangkul","year":"2025","unstructured":"Phokaewvarangkul O, Panyakaew P, Sringean J, Jankates W, Phumphid S, Anan C, Sanyawut K, Bhidayasiri R (2025b) Unlocking the daily impact of parkinson\u2019s challenges through a comprehensive assessment using the ChulaPD ADL questionnaire. Sci Rep 15(1):26212. https:\/\/doi.org\/10.1038\/s41598-025-09444-7","journal-title":"Sci Rep"},{"key":"3257_CR111","doi-asserted-by":"publisher","first-page":"107275","DOI":"10.1016\/j.parkreldis.2025.107275","volume":"132","author":"W Phuenpathom","year":"2025","unstructured":"Phuenpathom W, Phokaewvarangkul O, Bhidayasiri R (2025) Detecting freezing of gait: A comprehensive toolkit for enhanced Parkinson\u2019s assessment. Parkinsonism Relat Disord 132:107275. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107275","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"3257_CR112","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1007\/s00415-024-12669-7","volume":"271","author":"A Pilotto","year":"2024","unstructured":"Pilotto A, Ashton NJ, Lupini A, Battaglio B, Zatti C, Trasciatti C, Gipponi S, Cottini E, Grossi I, Salvi A, de Petro G, Pizzi M, Canale A, Blennow K, Zetterberg H, Padovani A (2024) Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson\u2019s disease. J Neurol 271(12):7537\u20137546. https:\/\/doi.org\/10.1007\/s00415-024-12669-7","journal-title":"J Neurol"},{"key":"3257_CR113","doi-asserted-by":"publisher","first-page":"101569","DOI":"10.1016\/j.lanepe.2025.101569","volume":"62","author":"W Pirker","year":"2026","unstructured":"Pirker W, Ferreira JJ, Rascol O, Poewe W (2026) Management of Parkinson\u2019s disease psychosis-a European perspective. Lancet Reg Health Eur 62:101569. https:\/\/doi.org\/10.1016\/j.lanepe.2025.101569","journal-title":"Lancet Reg Health Eur"},{"issue":"11","key":"3257_CR114","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00702-024-02843-6","volume":"131","author":"Z Pirto\u0161ek","year":"2024","unstructured":"Pirto\u0161ek Z (2024) Breaking barriers in Parkinson\u2019s care: the multidisciplinary team approach. J Neural Transm (Vienna) 131(11):1349\u20131361. https:\/\/doi.org\/10.1007\/s00702-024-02843-6","journal-title":"J Neural Transm (Vienna)"},{"issue":"2","key":"3257_CR115","doi-asserted-by":"publisher","first-page":"e200599","DOI":"10.1212\/CPJ.0000000000200599","volume":"16","author":"M Pudis","year":"2026","unstructured":"Pudis M, Rodr\u00edguez-Bel L, Cort\u00e9s-Romera M, Su\u00e1rez-Pi\u00f1era M (2026) Dopaminergic Pathway Imaging. Neurol Clin Pract 16(2):e200599. https:\/\/doi.org\/10.1212\/CPJ.0000000000200599","journal-title":"Neurol Clin Pract"},{"issue":"2","key":"3257_CR116","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00702-025-02990-4","volume":"133","author":"M Regensburger","year":"2026","unstructured":"Regensburger M, Csoti I, Jost WH, Kohl Z, Lorenzl S, Pedrosa DJ, Lingor P (2026) Motor and non-motor fluctuations in Parkinson\u2019s disease: the knowns and unknowns of current therapeutic approaches. J Neural Transm (Vienna) 133(2):309\u2013324. https:\/\/doi.org\/10.1007\/s00702-025-02990-4","journal-title":"J Neural Transm (Vienna)"},{"issue":"6","key":"3257_CR117","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00702-025-02893-4","volume":"132","author":"P Riederer","year":"2025","unstructured":"Riederer P, Strobel S, Nagatsu T, Watanabe H, Chen X, Loschmann PA, Sian-Hulsmann J, Jost WH, Muller T, Dijkstra JM, Monoranu CM (2025) Levodopa treatment: impacts and mechanisms throughout Parkinson\u2019s disease progression. J Neural Transm (Vienna) 132(6):743\u2013779. https:\/\/doi.org\/10.1007\/s00702-025-02893-4","journal-title":"J Neural Transm (Vienna)"},{"key":"3257_CR118","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-026-03142-y","author":"J Rodriguez-Antiguedad","year":"2026","unstructured":"Rodriguez-Antiguedad J, Bojtos L, Kulisevsky J (2026) A narrative review of clinical and non-clinical determinants of health-related quality of life in advanced Parkinson\u2019s disease. J Neural Transm. https:\/\/doi.org\/10.1007\/s00702-026-03142-y","journal-title":"J Neural Transm"},{"key":"3257_CR119","doi-asserted-by":"publisher","first-page":"1470928","DOI":"10.3389\/fneur.2024.1470928","volume":"15","author":"D Rodr\u00edguez-Mart\u00edn","year":"2024","unstructured":"Rodr\u00edguez-Mart\u00edn D, P\u00e9rez-L\u00f3pez C (2024) Commercial symptom monitoring devices in Parkinson\u2019s disease: benefits, limitations, and trends. Front Neurol 15:1470928. https:\/\/doi.org\/10.3389\/fneur.2024.1470928","journal-title":"Front Neurol"},{"key":"3257_CR120","doi-asserted-by":"publisher","first-page":"106982","DOI":"10.1016\/j.parkreldis.2024.106982","volume":"124","author":"D Safarpour","year":"2024","unstructured":"Safarpour D, Stover N, Shprecher DR, Hamedani AG, Pfeiffer RF, Parkman HP, Quigley EM, Cloud LJ, Other Non-motor Features Working Group of the Parkinson Study G (2024) Consensus practice recommendations for management of gastrointestinal dysfunction in Parkinson disease. Parkinsonism Relat Disord 124:106982. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106982","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"3257_CR121","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18(7):435\u2013450. https:\/\/doi.org\/10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"3257_CR122","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s00702-025-02942-y","volume":"132","author":"N Schr\u00f6ter","year":"2025","unstructured":"Schr\u00f6ter N, Groppa S, Rijntjes M, Gonzalez-Escamilla G, Urbach H, Jost WH, Rau A (2025) Neuroimaging in advanced Parkinson\u2019s disease: insights into pathophysiology, biomarkers, and personalized therapies. J Neural Transm (Vienna) 132(11):1655\u20131664. https:\/\/doi.org\/10.1007\/s00702-025-02942-y","journal-title":"J Neural Transm (Vienna)"},{"issue":"7","key":"3257_CR123","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3233\/jpd-212749","volume":"12","author":"L Sch\u00fctz","year":"2022","unstructured":"Sch\u00fctz L, Sixel-D\u00f6ring F, Hermann W (2022) Management of Sleep Disturbances in Parkinson\u2019s Disease. J Parkinsons Dis 12(7):2029\u20132058. https:\/\/doi.org\/10.3233\/jpd-212749","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"3257_CR124","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C, the collaborators of the Parkinson\u2019s Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine C (2019) Update on treatments for nonmotor symptoms of Parkinson\u2019s disease-an evidence-based medicine review. Mov Disord 34(2):180\u2013198. https:\/\/doi.org\/10.1002\/mds.27602","journal-title":"Mov Disord"},{"issue":"3","key":"3257_CR125","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00415-019-09184-5","volume":"266","author":"A Sesar","year":"2019","unstructured":"Sesar A, Fernandez-Pajarin G, Ares B, Relova JL, Aran E, Rivas MT, Gelabert-Gonzalez M, Castro A (2019) Continuous subcutaneous apomorphine in advanced Parkinson\u2019s disease patients treated with deep brain stimulation. J Neurol 266(3):659\u2013666. https:\/\/doi.org\/10.1007\/s00415-019-09184-5","journal-title":"J Neurol"},{"key":"3257_CR126","volume-title":"The Complete Works","author":"W Shakespeare","year":"2005","unstructured":"Shakespeare W (2005) Romeo and Juliet. Act2, Scene 2. In: Wells S, Taylor GM (eds) The Complete Works, 2nd edn. Clarendon, Oxford","edition":"2"},{"issue":"5","key":"3257_CR127","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, Tanner CM, Weintraub D, Videnovic A, Choi SH, Kurth R, Caspell-Garcia C, Coffey CS, Frasier M, Oliveira LMA, Hutten SJ, Sherer T, Marek K, Soto C (2023) Parkinson\u2019s Progression Markers I Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using alpha-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22(5):407\u2013417. https:\/\/doi.org\/10.1016\/S1474-4422(23)00109-6","journal-title":"Lancet Neurol"},{"issue":"2","key":"3257_CR128","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, Kieburtz K, Kopil CM, Merchant K, Mollenhauer B, Montine T, Nudelman K, Pagano G, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tanner CM, Tolosa E, Weintraub D, Xiao Y, Siderowf A, Dunn B, Marek K (2024) A biological definition of neuronal alpha-synuclein disease: towards an integrated staging system for research. Lancet Neurol 23(2):178\u2013190. https:\/\/doi.org\/10.1016\/S1474-4422(23)00405-2","journal-title":"Lancet Neurol"},{"issue":"1","key":"3257_CR129","doi-asserted-by":"publisher","first-page":"e000573","DOI":"10.1136\/bmjno-2023-000573","volume":"6","author":"V Sisodia","year":"2024","unstructured":"Sisodia V, Dubbeld L, De Bie RMA, Duarte GS, Costa J, Dijk JM (2024) Efficacy and safety of adjunctive oral therapy in Parkinson\u2019s disease with motor complications: a systematic review and network meta-analysis. BMJ Neurol Open 6(1):e000573. https:\/\/doi.org\/10.1136\/bmjno-2023-000573","journal-title":"BMJ Neurol Open"},{"issue":"3","key":"3257_CR131","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3233\/JPD-191604","volume":"9","author":"N Smith","year":"2019","unstructured":"Smith N, Brennan L, Gaunt DM, Ben-Shlomo Y, Henderson E (2019) Frailty in Parkinson\u2019s Disease: A Systematic Review. J Parkinsons Dis 9(3):517\u2013524. https:\/\/doi.org\/10.3233\/JPD-191604","journal-title":"J Parkinsons Dis"},{"key":"3257_CR130","doi-asserted-by":"publisher","first-page":"971252","DOI":"10.3389\/fneur.2022.971252","volume":"13","author":"LJ Smith","year":"2022","unstructured":"Smith LJ, Lee CY, Menozzi E, Schapira AHV (2022) Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease. Front Neurol 13:971252. https:\/\/doi.org\/10.3389\/fneur.2022.971252","journal-title":"Front Neurol"},{"issue":"1","key":"3257_CR132","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12883-022-02554-z","volume":"22","author":"A Stefani","year":"2022","unstructured":"Stefani A, Tessitore A, Tambasco N, Cossu G, Ceravolo MG, Defazio G, Morgante F, Ramat S, Melzi G, Gualberti G, Merolla R, Onuk K, Lopiano L (2022) Criteria for identification of advanced Parkinson\u2019s disease: the results of the Italian subgroup of OBSERVE-PD observational study. BMC Neurol 22(1):41. https:\/\/doi.org\/10.1186\/s12883-022-02554-z","journal-title":"BMC Neurol"},{"issue":"9","key":"3257_CR133","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/WNL.0b013e318285c0ed","volume":"80","author":"A Storch","year":"2013","unstructured":"Storch A, Schneider CB, Wolz M, Sturwald Y, Nebe A, Odin P, Mahler A, Fuchs G, Jost WH, Chaudhuri KR, Koch R, Reichmann H, Ebersbach G (2013) Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 80(9):800\u2013809. https:\/\/doi.org\/10.1212\/WNL.0b013e318285c0ed","journal-title":"Neurology"},{"issue":"1","key":"3257_CR134","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41746-024-01217-2","volume":"7","author":"YM Sun","year":"2024","unstructured":"Sun YM, Wang ZY, Liang YY, Hao CW, Shi CH (2024) Digital biomarkers for precision diagnosis and monitoring in Parkinson\u2019s disease. NPJ Digit Med 7(1):218. https:\/\/doi.org\/10.1038\/s41746-024-01217-2","journal-title":"NPJ Digit Med"},{"issue":"3","key":"3257_CR135","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5603\/pjnns.107157","volume":"60","author":"S Szlufik","year":"2026","unstructured":"Szlufik S, Jaros K, Milanowski L, Mandat T, Koziorowski D (2026) Adding continuous infusion therapies after bilateral subthalamic deep brain stimulation in advanced Parkinson\u2019s disease: clinical outcomes and quality of life assessment in a case series. Neurol Neurochir Pol 60(3):300\u2013309. https:\/\/doi.org\/10.5603\/pjnns.107157","journal-title":"Neurol Neurochir Pol"},{"key":"3257_CR136","doi-asserted-by":"publisher","first-page":"e89057","DOI":"10.2196\/89057","volume":"28","author":"J Tan","year":"2026","unstructured":"Tan J, Deng X, Wu C, Yao M, Liao J, Zheng H, Lian C (2026) Multimodal Intelligent Monitoring of Parkinson Disease: Scoping Review of Progress and Translational Challenges. J Med Internet Res 28:e89057. https:\/\/doi.org\/10.2196\/89057","journal-title":"J Med Internet Res"},{"key":"3257_CR137","doi-asserted-by":"publisher","first-page":"102081","DOI":"10.1016\/j.artmed.2021.102081","volume":"117","author":"AM Tautan","year":"2021","unstructured":"Tautan AM, Ionescu B, Santarnecchi E (2021) Artificial intelligence in neurodegenerative diseases: A review of available tools with a focus on machine learning techniques. Artif Intell Med 117:102081. https:\/\/doi.org\/10.1016\/j.artmed.2021.102081","journal-title":"Artif Intell Med"},{"issue":"5","key":"3257_CR138","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s00415-018-8816-9","volume":"265","author":"A Tessitore","year":"2018","unstructured":"Tessitore A, Marano P, Modugno N, Pontieri FE, Tambasco N, Canesi M, Latorre A, Lopiano L, Sensi M, Quatrale R, Solla P, Defazio G, Melzi G, Costanzo AM, Gualberti G, di Paparatti L, Antonini U A (2018) Caregiver burden and its related factors in advanced Parkinson\u2019s disease: data from the PREDICT study. J Neurol 265(5):1124\u20131137. https:\/\/doi.org\/10.1007\/s00415-018-8816-9","journal-title":"J Neurol"},{"key":"3257_CR139","doi-asserted-by":"publisher","first-page":"107115","DOI":"10.1016\/j.parkreldis.2024.107115","volume":"127","author":"A Thaler","year":"2024","unstructured":"Thaler A, Anis S, Ponger P, Fay-Karmon T, Livneh V, Faust-Socher A, Greenbaum L, Reiner J, Hilel A, Shabtai H, Alcalay RN, Djaldetti R, Hassin-Baer S, Ezra A, Mirelman A, Giladi N, Gurevich T (2024) Levodopa-carbidopa intestinal gel for advanced Parkinson\u2019s disease: Impact of LRRK2 and GBA1 mutations. Parkinsonism Relat Disord 127:107115. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107115","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"3257_CR140","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1474-4422(25)00033-X","volume":"24","author":"M Tinazzi","year":"2025","unstructured":"Tinazzi M, Gandolfi M, Artusi CA, Bannister K, Rukavina K, Brefel-Courbon C, de Andrade DC, Perez-Lloret S, Mylius V (2025) Advances in diagnosis, classification, and management of pain in Parkinson\u2019s disease. Lancet Neurol 24(4):331\u2013347. https:\/\/doi.org\/10.1016\/S1474-4422(25)00033-X","journal-title":"Lancet Neurol"},{"issue":"12","key":"3257_CR141","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00702-017-1799-3","volume":"124","author":"N Titova","year":"2017","unstructured":"Titova N, Martinez-Martin P, Katunina E, Chaudhuri KR (2017) Advanced Parkinson\u2019s or complex phase Parkinson\u2019s disease? Re-evaluation is needed. J Neural Transm (Vienna) 124(12):1529\u20131537. https:\/\/doi.org\/10.1007\/s00702-017-1799-3","journal-title":"J Neural Transm (Vienna)"},{"issue":"6","key":"3257_CR142","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41582-025-01079-6","volume":"21","author":"A Tosserams","year":"2025","unstructured":"Tosserams A, Fasano A, Gilat M, Factor SA, Giladi N, Lewis SJG, Moreau C, Bloem BR, Nieuwboer A, Nonnekes J (2025) Management of freezing of gait - mechanism-based practical recommendations. Nat Rev Neurol 21(6):327\u2013344. https:\/\/doi.org\/10.1038\/s41582-025-01079-6","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"3257_CR143","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2174\/1570159x20666220315163856","volume":"21","author":"DJV Wamelen","year":"2023","unstructured":"Wamelen DJV, Rukavina K, Podlewska AM, Chaudhuri KR (2023) Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinson\u2019s Disease: An Update Since 2017. Curr Neuropharmacol 21(8):1786\u20131805. https:\/\/doi.org\/10.2174\/1570159x20666220315163856","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"3257_CR144","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00702-024-02807-w","volume":"131","author":"D Weise","year":"2024","unstructured":"Weise D, Claus I, Dresel C, Kalbe E, Liepelt-Scarfone I, Lorenzl S, Redecker C, Urban PP (2024) Multidisciplinary care in Parkinson\u2019s disease. J Neural Transm (Vienna) 131(10):1217\u20131227. https:\/\/doi.org\/10.1007\/s00702-024-02807-w","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"3257_CR145","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s40120-025-00747-5","volume":"14","author":"N Williamson","year":"2025","unstructured":"Williamson N, Morel T, Bradley H, Lydon A, Clifford M, Cronin P, Biagioni M (2025) Understanding the Patient Experience of Advanced Parkinson\u2019s Disease: Qualitative Research with Patients and Expert Clinicians to Identify Symptoms and Associated Health-Related Quality of Life Impacts. Neurol Ther 14(4):1383\u20131417. https:\/\/doi.org\/10.1007\/s40120-025-00747-5","journal-title":"Neurol Ther"},{"issue":"9","key":"3257_CR146","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/PHM.0000000000001923","volume":"101","author":"ISK Wong-Yu","year":"2022","unstructured":"Wong-Yu ISK, Ren L, Mak MKY (2022) Impaired Hand Function and Its Association With Self-Perceived Hand Functional Ability and Quality of Life in Parkinson Disease. Am J Phys Med Rehabil 101(9):843\u2013849. https:\/\/doi.org\/10.1097\/PHM.0000000000001923","journal-title":"Am J Phys Med Rehabil"},{"issue":"1","key":"3257_CR147","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41531-022-00383-y","volume":"8","author":"A Zampogna","year":"2022","unstructured":"Zampogna A, Cavallieri F, Bove F, Suppa A, Castrioto A, Meoni S, P\u00e9lissier P, Schmitt E, Bichon A, Lhomm\u00e9e E, Kistner A, Chabard\u00e8s S, Seigneuret E, Fraix V, Moro E (2022) Axial impairment and falls in Parkinson\u2019s disease: 15 years of subthalamic deep brain stimulation. npj Parkinson\u2019s Disease 8(1):121. https:\/\/doi.org\/10.1038\/s41531-022-00383-y","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"1","key":"3257_CR148","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/s41467-024-49949-9","volume":"15","author":"A Zarkali","year":"2024","unstructured":"Zarkali A, Thomas GEC, Zetterberg H, Weil RS (2024) Neuroimaging and fluid biomarkers in Parkinson\u2019s disease in an era of targeted interventions. Nat Commun 15(1):5661. https:\/\/doi.org\/10.1038\/s41467-024-49949-9","journal-title":"Nat Commun"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03257-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03257-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03257-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T12:27:24Z","timestamp":1785587244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-026-03257-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":148,"alternative-id":["3257"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03257-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"assertion":[{"value":"11 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"OP declare no competing interests. RB has provided consultancy services, and has received honoraria and lecture fees from industries such as Britannia, Ipsen, Teva-Lundbeck, and Mitsubishi-Tanabe. Bhidayasiri holds patents for various innovations, including a laser-guided walking stick, a portable tremor device, technology for monitoring during the night, an electronic diary for Parkinson\u2019s disease symptoms, as well as the Parkinson insole and shoe, and anti-choking mugs. Furthermore, his copyrighted works comprise the application for screening Parkinson\u2019s disease (Check PD), a Parkinson\u2019s mascot, a daily activity diary for Parkinson\u2019s, creative dopamine-themed lyrics, and educational video content focusing on common nighttime and gastrointestinal symptoms associated with Parkinson\u2019s disease.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}